Literature DB >> 24718613

Emerging Trichosporon asahii in elderly patients: epidemiological and molecular analysis by the DiversiLab system.

M Treviño1, C García-Riestra, P Areses, X García, D Navarro, F J Suárez, I A López-Dequidt, O Zaragoza, M Cuenca-Estrella.   

Abstract

Trichosporon asahii has been recognized as an emerging opportunistic agent for invasive infections, mainly in immunocompromised patients. Urinary tract infections by this pathogen may also occur, especially in patients with urinary obstruction or those undergoing vesical catheterization and antibiotic treatment. Many outbreaks of Trichosporon spp. have been detected after urinary catheter manipulations. We report the molecular-epidemiological characterization of T. asahii in our institution using the DiversiLab system for the molecular strain typing and compare three different methods for susceptibility testing. Our results present T. asahii as an emergent pathogen in elderly patients with urinary drainage devices that can be adequately treated with triazoles, with voriconazole being the most active. Broth dilution and Vitek 2 had good concordance, while Etest showed more discrepancies. In addition, the DiversiLab system for clonal strain typing may be a useful tool for fast and accurate management of nosocomial outbreaks.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24718613     DOI: 10.1007/s10096-014-2099-6

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  27 in total

1.  Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates.

Authors:  Moan Shane Tsai; Yun Liang Yang; An Huei Wang; Lih Shinn Wang; Daniel C T Lu; Ci Hong Liou; Li Yun Hsieh; Chi Jung Wu; Ming Fang Cheng; Zhi Yuan Shi; Hsiu Jung Lo
Journal:  Mycopathologia       Date:  2012-02-09       Impact factor: 2.574

2.  Microbial DNA typing by automated repetitive-sequence-based PCR.

Authors:  Mimi Healy; Joe Huong; Traci Bittner; Maricel Lising; Stacie Frye; Sabeen Raza; Robert Schrock; Janet Manry; Alex Renwick; Robert Nieto; Charles Woods; James Versalovic; James R Lupski
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

3.  Use of the Diversi Lab System for species and strain differentiation of Fusarium species isolates.

Authors:  M Healy; K Reece; D Walton; J Huong; S Frye; I I Raad; D P Kontoyiannis
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

Review 4.  Update on the genus Trichosporon.

Authors:  Thomas C Chagas-Neto; Guilherme M Chaves; Arnaldo L Colombo
Journal:  Mycopathologia       Date:  2008-06-21       Impact factor: 2.574

5.  Susceptibility patterns and molecular identification of Trichosporon species.

Authors:  Juan L Rodriguez-Tudela; Teresa M Diaz-Guerra; Emilia Mellado; Virginia Cano; Cecilia Tapia; Alexander Perkins; Alicia Gomez-Lopez; Laura Rodero; Manuel Cuenca-Estrella
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

6.  Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases.

Authors:  Dimitrios P Kontoyiannis; Michail S Lionakis; Russell E Lewis; Georgios Chamilos; Mimi Healy; Cheryl Perego; Amar Safdar; Hagop Kantarjian; Richard Champlin; Thomas J Walsh; Issam I Raad
Journal:  J Infect Dis       Date:  2005-03-16       Impact factor: 5.226

7.  DNA fingerprinting of Candida rugosa via repetitive sequence-based PCR.

Authors:  R J Redkar; M P Dubé; F K McCleskey; M G Rinaldi; V G Del Vecchio
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

Review 8.  [Nosocomial infection due to Trichosporon asahii: clinical revision of 22 cases].

Authors:  Gustavo da Silva Rodrigues; Rodrigo Rosa Ubatuba de Faria; Lucina Silva Guazzelli; Flávio de Mattos Oliveira; Luiz Carlos Severo
Journal:  Rev Iberoam Micol       Date:  2006-06       Impact factor: 1.044

9.  Head-to-head comparison of inhibitory and fungicidal activities of fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against clinical isolates of Trichosporon asahii.

Authors:  Gulsen Hazirolan; Emilia Canton; Selma Sahin; Sevtap Arikan-Akdagli
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

10.  Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan.

Authors:  Sheng-Yuan Ruan; Jung-Yien Chien; Po-Ren Hsueh
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

View more
  1 in total

1.  Molecular epidemiology of Cryptococcus neoformans and Cryptococcus gattii in China between 2007 and 2013 using multilocus sequence typing and the DiversiLab system.

Authors:  H-T Dou; Y-C Xu; H-Z Wang; T-S Li
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-12-04       Impact factor: 3.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.